Stem Cell and Regenerative Medicine

Open Access ISSN: 2639-9512

Stem Cell & Regenerative Medicine (ISSN 2639-9512) is a peer-reviewed international open access journal publishing high-quality manuscripts focusing on the biology and applications of stem cell research. Journal of Stem Cell Research accepts articles related to Stem Cell Research and Regenerative Medicine, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, genomics and translational research articles related to all fields of stem cell from traditional, translational and Clinical research.

Stem Cell & Regenerative Medicine publishes Original articles, Short reports, Reviews, Commentaries, Communications, Case Studies, etc.

Our journal strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. Stem Cell & Regenerative Medicine will keep up-to- date with the latest advancements in the feilds of stemcell research. Abstracts and Pdfs of all articles published are freely available to everyone immediately after publication.

Authors are requested to submit manuscripts as an e-mail attachment to the Editorial Office at stemcellresearch@scivisionjournals.com.

Recent Articles


Research Article DOI: JSCR-21-061
Traumatic Spinal Cord Injury at T12 Causing Complete Paraplegia for 12-Years Duration Treated with Autologous Telomerase Positive Stem Cells

Authors: Henry E. Young, Mark O. Speight.

Research Article DOI: JSCR-21-062
Differentiation of Mouse Embryonic Fibroblasts (MEFs) into Cardiomyocytes Using Human-Derived Cardiac Inducing RNA (CIR)

Authors: Larry F. Lemanski, Andrei Kochegarov, Kamran Kaveh, Michael Neal, Ashley Arms, Yelica L Rodriguez, Lan Hong, M. Javed Equbal, Pipasha Biswas, Priya Biswas, Matthew Gonzalez, Jewel Ross-Ferguson, Justin Rusk, Lani Lyman- Henley, Tearah McRae-Kee, Curtis Ivory, Zhengshan Zhao.

Research Article DOI: JSCR-21-063
Blunt Force Trauma-Induced Total Bilateral Visual Impairment of 13 Years Duration Treated with Autologous Telomerase-Positive Stem Cells

Authors: Henry E. Young, Mark O. Speight.

Research Article DOI: JSCR-21-064
An Alternative Novel Therapy for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: Adult Autologous Telomerase-Positive Stem Cells

Authors: Henry E. Young, Mark O. Speight.

Research Article DOI: JSCR-21-065
The Cure of Human Type 2 Diabetes via Systematic Transplantations of dgHPSCs Overexpressing Human ERRĪ³ and/or Insulin Genes (I)

Authors: Taihua Wang, Xiaohui Cui, Zhenzhen Yang, Linyu Cui, Rongrong Li, Xinyi Shi, Xiaoxia Jiang, Shufeng Du, Mengqian Wang, Ning Zuo, Guoke Yang, Ying Meng, and Gang Zhang.